NEW YORK, May 2 - Large Scale Biology reported revenues of $6 million for the first quarter of 2001, up from $5.6 million from the company's first quarter revenues for 2000, the company said Wednesday.

The increase reflects slightly higher revenue from a research contract with Dow Chemical and Dow AgroSciences. The contract accounted for 87 percent of Large Scale Biology's revenue last year, and 88 percent in the first quarter of this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.